🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

19 recruiting trials

for Chondrosarcomas

Adherence to a Personalized Home Exercise Program in Patients With Bone Tumor Undergoing Lower Extremity Salvage Surgery NCT05779670n/a1 site📍 Bologna Istituto Ortopedico Rizzoli Proton or Photon RT for Retroperitoneal Sarcomas NCT01659203Phase 1, Phase 210 sites📍 Chicago📍 Boston📍 Boston Massachusetts General Hospital · Tests: IG-IMPT, IG IMRT Hypofractionated Protontherapy in Chordomas and Chondrosarcomas of the Skull Base NCT05861245NA1 site📍 Madrid Quironsalud · Tests: 5-fraction hipofractionated protontheray, 25-fraction hypofractionated proton therapy Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone NCT05033288n/a3 sites📍 Scottsdale📍 Jacksonville📍 Rochester Mayo Clinic · Tests: Electronic Health Record Review, Quality-of-Life Assessment IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors NCT05039801Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Bevacizumab, Glutaminase-1 Inhibitor IACS-6274, Paclitaxel, Capivasertib Clinical Applicability of Liquid Biopsy in Chondrosarcoma NCT07492823n/a1 site📍 Graz Medical University of Graz · Tests: laboratory biomarker analysis, Molecular pathology PET-imaging of Two Vartumabs in Patients With Solid Tumors NCT06645808EARLY Phase 11 site📍 Groningen Var2 Pharmaceuticals · Tests: 89Zr-DFO-N-Suc-F8scFv, 89Zr-DFO-N-Suc-C9scFv, PET/CT scan NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) NCT06239272Phase 1, Phase 27 sites📍 Atlanta📍 Chicago📍 Baton Rouge St. Jude Children's Research Hospital · Tests: Surgical resection, Proton beam radiation therapy, Pazopanib, Ifosfamide, Doxorubicin Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas NCT04055220NA16 sites📍 Besançon📍 Bordeaux📍 Lille Centre Leon Berard · Tests: Treatment by Regorafenib, Surveillance Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration NCT04040205Phase 24 sites📍 Jacksonville📍 Iowa City📍 St Louis Medical College of Wisconsin · Tests: Abemaciclib Diagnostic and Therapeutic Targets in Cartilaginous Tumours NCT07315542n/a1 site📍 Brno St. Anne's University Hospital Brno, Czech Republic · Tests: Tumour tissue analysis, Molecular validation, Liquid biopsy analysis Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors NCT06176989Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: Enasidenib A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning NCT06387485NA3 sites📍 Oakland📍 Royal Oak📍 Columbus Ricoh USA, Inc. · Tests: 3D Printed Anatomic Model, CT/MRI Study on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma NCT04305548Phase 27 sites📍 Prato📍 Roma📍 Candiolo Italian Sarcoma Group · Tests: Trabectedin Image Assisted Optimization of Proton Radiation Therapy in Chordomas and Chondrosarcomas NCT04832620n/a2 sites📍 Delft📍 Leiden Leiden University Medical Center Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas NCT03442465n/a5 sites📍 Basking Ridge📍 Middletown📍 Harrison Memorial Sloan Kettering Cancer Center · Tests: Toronto Extremity Salvage Score, Musculoskeletal Tumor Society Score, Timed Get Up and Go Test, Orthogonal Radiographs,… Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen NCT06127407Phase 3115 sites📍 Los Angeles📍 Santa Monica📍 Aurora Servier Bio-Innovation LLC · Tests: Ivosidenib 500mg, Placebo Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy NCT06029218NA1 site📍 Nice Centre Antoine Lacassagne · Tests: Proteus ONE one daily beam, Proteus ONE two daily beam Uncovering Genes Behind Cartilage Tumors and Vascular Anomalies Using Genomic Sequencing NCT06749366n/a1 site📍 Bethesda Eunice Kennedy Shriver National Institute of Child Health a…
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy